Literature DB >> 19417682

The prevalence of and risk factors for Barrett's esophagus in a Korean population: A nationwide multicenter prospective study.

Jong-Jae Park1, Jae Woo Kim, Hyun Jin Kim, Moon Gi Chung, Seon Mee Park, Gwang Ho Baik, Byung Kyu Nah, Su Youn Nam, Kang Seok Seo, Byung Sung Ko, Jae-Young Jang, Byeong Gwan Kim, Ji Won Kim, Youn Seon Choi, Moon Kyung Joo, Jin Il Kim, Mee-Yon Cho, Nayoung Kim, Soo-Heon Park, Hyun Chae Jung, In-Sik Chung.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prevalence of Barrett's esophagus (BE) in the general Korean population by evaluating screening esophagogastroduodenoscopy. In addition, the risk factors for BE were identified.
METHOD: An esophagogastroduodenoscopy examination was performed in 25,536 subjects who had upper endoscopy screening from January 2006 to July 2006.
RESULTS: Two hundred and fifteen subjects were confirmed to have BE by pathology, thus the prevalence of BE was calculated to be 0.84%. The endoscopic findings were subdivided into 2 groups: BE without reflux esophagitis (RE), which included 167 (77.7%), and BE with RE, which included 48 (22.3%). The analysis of symptoms showed that only 60.1% of the subjects with BE had reflux symptoms. Chest pain [odds ratio (OR): 1.48, 95% confidence interval (CI): 1.04-2.11] and epigastric soreness (OR: 1.42, 95% CI: 1.05-1.93) were found more frequently in the subjects with BE compared with the normal subjects. The multivariate analysis showed that the risk factors for all subjects with BE were a male sex (OR: 1.82, 95% CI: 1.32-2.50), nonsteroidal anti-inflammatory drug use (OR: 2.02, 95% CI: 1.28-3.20), hiatal hernia (OR: 5.66, 95% CI: 3.70-8.66), and an age > or = 60 compared with an age < 40 (OR: 1.81, 95% CI: 1.07-3.09). There was no significant difference associated with RE.
CONCLUSIONS: The prevalence of BE in Korean patients presenting for a routine health check-up was 0.84%, lower than reported in Western countries. Among the subjects with BE 77.7% did not have endoscopic erosions and there were no reflux symptoms in 39.9%. These results suggest that regular endoscopic screening with a high index of suspicion is necessary for the diagnosis of BE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417682     DOI: 10.1097/MCG.0b013e318196bd11

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  26 in total

1.  Cardiac mucosa at the gastroesophageal junction: An Eastern perspective.

Authors:  Ahrong Kim; Won-Young Park; Nari Shin; Hyun Jung Lee; Young Keum Kim; So Jeong Lee; Cheong-Soo Hwang; Do Youn Park; Gwang Ha Kim; Bong Eun Lee; Hong-Jae Jo
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

2.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

3.  Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea.

Authors:  Jung Wan Choe; Young Choon Kim; Moon Kyung Joo; Hyo Jung Kim; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Jae Seon Kim; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastrointest Endosc       Date:  2016-04-25

4.  Interobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study.

Authors:  Y C Lee; M B Cook; S Bhatia; W H Chow; E M El-Omar; H Goto; J T Lin; Y Q Li; P L Rhee; P Sharma; J J Sung; J Y Wong; J C Wu; K Y Ho
Journal:  Endoscopy       Date:  2010-08-30       Impact factor: 10.093

5.  Gallstones increase the prevalence of Barrett's esophagus.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Keiko Asakura; Yoshimasa Saito; Kenro Hirata; Toru Takebayashi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

6.  Significance of Persistent Nondysplasia Over Multiple Endoscopic Surveillance in Risk Stratification of Patients With Barrett's Esophagus (Gastroenterology 2013;145:548-553, e1).

Authors:  Jeong Hwan Kim
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

7.  Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.

Authors:  Jennifer L Schneider; Wei K Zhao; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2014-09-12       Impact factor: 3.199

Review 8.  Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis.

Authors:  Seiji Shiota; Siddharth Singh; Ashraf Anshasi; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-07       Impact factor: 11.382

Review 9.  Meta-analysis of Barrett's esophagus in China.

Authors:  Ying Dong; Bing Qi; Xiao-Ying Feng; Chun-Meng Jiang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 10.  Current status of Barrett's esophagus research in Asia.

Authors:  Chi-Yang Chang; Michael B Cook; Yi-Chia Lee; Jaw-Town Lin; Takafumi Ando; Shobna Bhatia; Wong-Ho Chow; Emad M El-Omar; Hidemi Goto; Yang-Qing Li; Kenneth McColl; Nageshwar Reddy; Poong-Lyul Rhee; Prateek Sharma; Joseph J-Y Sung; Uday Ghoshal; Jennie Y-Y Wong; Justin C-Y Wu; Jun Zhang; Khek-Yu Ho
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.